Skip to main content
SpringerLink
Log in

Leflunomide: Inhibition of S-antigen induced autoimmune uveitis in Lewis rats

  • Molecular Immunopathology
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Leflunomide (LEF) is a novel immunomodulator which has been reported to be efficacious in experimental models of systemic autoimmune diseases and in treating rheumatoid arthritis in man. Leflunomide's ability to ameliorate ocular disease processes was investigated in a model of autoimmune eye disease, experimental autoimmune uveitis (EAU). EAU was induced by the injection of retinal S-antigen (S−Ag) into the foot-pad of Lewis rats. Leflunomide, or the reference compound cyclosporin A (CSA), was administered orally or topically (to one eye) each day beginning on the day of S−Ag injection. Drug efficacy was measured by the suppression in clinical signs of ocular inflammation and confirmed by histology. Both oral and topical ocular treatment with LEF suppressed the ocular disease signs and symptoms and retinal necrosis and reduced the S−Ag antibody levels associated with EAU in a dose-dependent manner. Both LEF and CSA were able to inhibit totally the disease manifestations of EAU; however, a comparison of the IC50 and IC90 values indicate that LEF is more potent than CSA in inhibiting EAU. These results suggest that leflunomide may be useful for treating autoimmune diseases of the eye.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. D. C. Herman,Subspecialty clinics: Ophthalmology. Endogenous uveitis: Current concepts of treatment. Mayo Clin. Proc.65, 671–683 (1990).

    PubMed  Google Scholar 

  2. R. B. Nussenblatt and A. G. Palestine,Uveitis Fundamentals and Clinical Practice, pp. 103–144, Year Book Medical Publishers, Inc., Chicago 1989.

    Google Scholar 

  3. R. R. Bartlett, M. Dimitrijevic, T. Mattar, T. Sielinski, T. Germann, E. Rude, G. H. Thoenes, C. C. A. Kuchle, H. U. Schorlemmer, E. Bremer, A. Finnegan and A. Schleyerbach,Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents and Actions32, 10–21 (1991).

    PubMed  Google Scholar 

  4. W. B. Wacker and M. M. Lipton,Experimental allergic uveitis: Homologous retina as uveitigenic antigen. Nature206, 253–254 (1965).

    PubMed  Google Scholar 

  5. W. B. Wacker and C. M. Kaslow,Autoimmune uveo-retinitis in the rat sensitized with retina photoreceptor cell antigen. Int. Arch. Allergy45, 582–592 (1973).

    PubMed  Google Scholar 

  6. Y. de Kozak, J. Sakai, B. Thillaye and J. P. Faure,S Antigen-induced experimental autoimmune uveo-retinitis in rats. Curr. Eye Res.1, 327–337 (1981).

    PubMed  Google Scholar 

  7. N. A. Rao, W. B. Wacker and G. E. Marak,Experimental allergic uveitis, clinicopathologic features associated with varying doses of S antigen. Arch. Ophthal.97, 1954–1958 (1979).

    PubMed  Google Scholar 

  8. Y. de Kozak, J. Sainte-Laudy, J. Benveniste and J. P. Faure,Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur. J. Immunol.11, 612–617 (1981).

    PubMed  Google Scholar 

  9. C. H. Lee, L. Smith Lang and E. L. Orr,Changes in ocular mast cell numbers and histamine distribution during experimental autoimmune uveitis. Reg. Immunol.5, 106–113 (1993).

    PubMed  Google Scholar 

  10. C. Dorey, J. Cozette and J. P. Faure,A simple and rapid method for isolation of retinal S antigen. Ophthal. Res.14, 249–255 (1982).

    Google Scholar 

  11. R. B. Hackett and T. O. McDonald,Eye irritation. In Dermatoxicology. 4th edition (Eds. F. N. Marzulli and H. I. Maibach) pp. 749–815. Hemisphere, Washington, DC 1991.

    Google Scholar 

  12. L. S. Lang, R. L. Glaser, L. K. Weimer and S. M. Robertson,The efficacy of topically applied Leflunomide and cyclosporin A in a model of autoimmune uveitis. InRecent Advances in Uveitis. Proc. 3rd Int. Symp. on Uveitis, Brussels, Belgium. (Eds. J. P. Dernouchamps, C. Verougstraete, L. Caspers-Velu and M. J. Tassignon) pp. 529–534. Kugler, Amsterdam 1993.

    Google Scholar 

  13. R. R. Bartlett, T. Mattar, U. Weithmann, H. Anagnostopoulos, S. Popovic and R. Schleyerbach,Leflunomide (HWA 486 A novel immunorestoring drug. InTherapeutic Approaches in Inflammatory Diseases. (Eds. A. J. Lewis, N. S. Doherty and N. R. Ackerman) pp. 215–228. Elsevier, New York 1989.

    Google Scholar 

  14. A. von Wartburg and R. Traber,Chemistry of the natural cyclosporin metabolites. InCiclosporin. Progress in Allergy, Vol. 38. (Ed. J. F. Borel) pp. 28–45, Karger, Basel 1986.

    Google Scholar 

  15. D. M. Maurice and S. Mishima,Ocular pharmacokinetics. InPharmacology of the Eye Handb. Exp. Pharm., Vol. 69. (Ed. M. L. Sears) pp. 27–36, Springer, Berlin 1984.

    Google Scholar 

  16. M. Mochizuki, T. Kuwabara, C. McAllister, R. B. Nussenblatt and I. Gery,Adoptive transfer of experimental autoimmune uveoretinitis in rats: Immunopathogenic mechanisms and histological features. Invest. Ophthal. Vis. Sci.26, 1–9 (1985).

    Google Scholar 

  17. R. R. Caspi, F. G. Roberge, C. G. McAllister, M. El-Saied, T. Kuwabara, I. Gery, E. Hanna and R. B. Nussenblatt,J cell lines mediating experimental autoimmune uveoretinitis (EAU in the rat). J. Immunol.136, 928–933 (1986).

    PubMed  Google Scholar 

  18. R. B. Nussenblatt, M. M. Rodriguez, W. B. Wacker, S. J. Cevario, Salinas-Carmona and I. Gery,Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats. J. Clin. Invest.67, 1228–1231 (1981).

    PubMed  Google Scholar 

  19. H. Kawashima, Y. Fujino and M. Mochizuki,Effects of a new immunosuppressive agent, FK 506, on experimental autoimmune uveoretinitis in rats. Invest. Ophthal. Vis. Sci.29, 1265–1271 (1988).

    PubMed  Google Scholar 

  20. L. Lang Smith, B. Glaser, L. K. Weimer, S. T. Miller, S. M. Robertson, K. R. Aoki and J. M. Yanni,Efficacy of novel immunomodulators leflunomide and rapamycin in autoimmune uveitis. FASEB J.4, A1048, Part 1 (1992).

    Google Scholar 

  21. F. J. Dumont, M. J. Staruch, S. L. Koprak, M. R. Melino and N. H. Sigal,Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol.144, 251–258 (1990).

    PubMed  Google Scholar 

  22. K. U. Weithmann, S. Jeske and V. Schlotte,Effect of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation. Agents and Actions41, 164–170 (1994).

    PubMed  Google Scholar 

  23. T. Zielinski, H.-J. Muller, R. R. Bartlett,Differential effects of leukocytes: Inhibition of rat in-vivo adhesion and human in-vitro oxidative burst without affecting surface marker modulation. Agents and Actions (in press).

Download references

Author information

Authors and Affiliations

  1. Research and Development, Alcon Laboratories Inc., 6201 South Freeway, 76134-2099, Fort Worth, TX, USA

    S. M. Robertson & L. S. Lang

Authors
  1. S. M. Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. S. Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robertson, S.M., Lang, L.S. Leflunomide: Inhibition of S-antigen induced autoimmune uveitis in Lewis rats. Agents and Actions 42, 167–172 (1994). https://doi.org/10.1007/BF01983486

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01983486

Key words

Search

Navigation